5% Off
5% Off
marketed by DELCURE LIFESCIENCES
• 60ML
₹77.33
M.R.P.: ₹81.4
5% Off
Inclusive of all taxes
WELMINIC is a combination of two medicines, namely chlorpheniramine maleate and phenylephrine hydrochloride. it works by narrowing the small blood vessels and provides relief from runny nose, stuffy nose, watery eyes and congestion. do not stop taking this syrup because your symptoms may come back and worsen the condition. take this syrup as directed by your doctor. the most common side effect
hypersensitivity pregnancy lactation liver disease heart disease hyperthyroidism glaucoma.
babies: safe if prescribed by your doctor.
lactating mother: consult your doctor because no studies have shown evidence of side effects during breastfeeding.
pregnancy: consult your doctor because no studies have shown evidence of risk to the developing baby.
driving: consult your doctor because this medication may alter your ability to drive.
do not drive if you experience these symptoms.
alcohol: avoid alcohol consumption while taking this medication and may cause liver damage.
kidney: consult your doctor because studies have shown limited evidence in patients with kidney disease.
liver: consult your doctor because studies have shown limited evidence in patients with liver disease.
.
Nausea Vomiting Headache Drowsiness.
WELMINIC works by narrowing the small blood vessels and provides relief from runny nose, stuffy nose, watery eyes and congestion..
If you miss a dose, take WELMINIC as soon as possible.
If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily.
Don't double the dose to catch up with the missed dose..
• WELMINIC needs to be taken as prescribed by your doctor.
• do not stop taking this syrup unless told by your doctor.
• do not use a household spoon as it may cause a missed dose.
• drink plenty of water while taking this medication.
• avoid alcohol consumption while taking this syrup as it may cause excessive drowsiness and sleepiness.
do not go for a drive if this symptom occurs..
• phenlephrine hydrochloride + acebutolol: concurrent use leads to increase in phenylephrine levels by decreasing acebutolol.
• chlorpheniramine maleate + acalabrutinib: concurrent use leads to increase in chlorpheniramine maleate levels by decreasing acalabrutinib.
• chlorpheniramine maleate + buserelin: concurrent use leads to risk of qtc prolongation.
• chlorpheniramine maleate + cenobamate: concurrent use leads to decrease in serum concentration levels.
.
100% Authentic
Easy Return